This proposal is designed to study the effects of disrupting PKA localization by the neural specific A-kinase anchoring protein, AKAP150. Elevations of cAMP within a cell occur as a result of the opposing actions of adenylyl cyclase and phosphodiestrerases. As a result, cAMP concentration fluctuations occur within rather limited microdomains of a cell. These facts, coupled with the very broad PKA specificity, make it reasonable that restricted subcellular localization is important in PKA signaling fidelity. One of our approaches to study the importance of localized docking of PKA is to create a line of knock-in mice, which carry a mutation in AKAP150. This mutation introduces a premature stop codon in the open reading frame and results in a 36 amino acid truncation of the C-terminal end of the protein, effectively eliminating any PKA docking site. The remainder of this scaffolding AKAP150 protein will remain intact. In a second approach, we will generate a line of mice carrying a complete knock-out of the AKAP150 gene. We anticipate that this will give rise to mice with a more marked phenotype as the complex knock-out will disrupt the signalling fidelity of several kinase and phosphatase pathways.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32NS010922-01A1
Application #
6207304
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (01))
Program Officer
Michel, Mary E
Project Start
2000-09-16
Project End
Budget Start
2000-09-16
Budget End
2001-08-10
Support Year
1
Fiscal Year
2000
Total Cost
$34,342
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195